|
Originally published In Press as doi:10.1074/jbc.M206235200 on August 27, 2002
J. Biol. Chem., Vol. 277, Issue 46, 44485-44496, November 15, 2002
Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells
Is Controlled by Glucose-regulated Upstream Stimulatory Factor and
Activator Protein-1 Activities*
Miri
Bidder §,
Jian-Su
Shao ,
Nichole
Charlton-Kachigian ,
Arleen P.
Loewy ,
Clay F.
Semenkovich§, and
Dwight A.
Towler §¶
From the Divisions of Bone and Mineral Diseases and
§ Endocrinology, Diabetes, and Metabolism, Department of
Internal Medicine, Washington University School of Medicine, St. Louis,
Missouri 63110
The expression of the matrix cytokine osteopontin
(OPN) is up-regulated in aortic vascular smooth muscle cells (VSMCs) by diabetes. OPN expression in cultured VSMCs is reciprocally
regulated by glucose and 2-deoxyglucose (2-DG; inhibitor of cellular
glucose metabolism). Systematic analyses of OPN
promoter-luciferase reporter constructs identify a CCTCATGAC
motif at nucleotides 80 to 72 relative to the initiation site that
supports OPN transcription in VSMCs. The region 83 to
45 encompassing this motif confers basal and glucose- and
2-DG-dependent transcription on an unresponsive promoter.
Competition and gel mobility supershift assays identify upstream
stimulatory factor (USF; USF1:USF2) and activator protein-1 (AP1;
c-Fos:c-Jun) in complexes binding the composite CCTCATGAC element.
Glucose up-regulates both AP1 and USF binding activities 2-fold in A7r5
cells and selectively up-regulates USF1 protein levels. By contrast,
USF (but not AP1) binding activity is suppressed by 2-DG and restored
by glucose treatment. Expression of either USF or AP1 activates the
proximal OPN promoter in A7r5 VSMCs in part via the
CCTCATGAC element. Moreover, glucose stimulates the transactivation
functions of c-Fos and USF1, but not c-Jun, in one-hybrid assays.
Mannitol does not regulate binding, transactivation functions, USF1
protein accumulation, or OPN transcription. Thus, OPN gene transcription is regulated by USF and AP1 in aortic VSMCs, entrained to changes in cellular glucose metabolism.
*
This work was supported by Grants HL69229 and DK52446 (to
D. A. T.) from the National Institutes of Health and by the
Barnes-Jewish Hospital Research Foundation.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Washington
University Medical Center, Division of Bone and Mineral Diseases,
Barnes-Jewish Hospital, North Campus, 216 South Kingshighway Blvd., St.
Louis, MO 63110. Tel.: 314-454-7434; Fax: 314-454-5047; E-mail:
dtowler@im.wustl.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Shi, D. Nikolic, S. Liu, H. Lu, and S. Wang
Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice
Am J Physiol Renal Physiol,
February 1, 2009;
296(2):
F257 - F265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Eferl, P. Hasselblatt, M. Rath, H. Popper, R. Zenz, V. Komnenovic, M.-H. Idarraga, L. Kenner, and E. F. Wagner
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
PNAS,
July 29, 2008;
105(30):
10525 - 10530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Whalen, G. F. Weber, T. L. Benjamin, and B. S. Schaffhausen
Polyomavirus Middle T Antigen Induces the Transcription of Osteopontin, a Gene Important for the Migration of Transformed Cells
J. Virol.,
May 15, 2008;
82(10):
4946 - 4954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kristiansson, E. Ilveskoski, T. Lehtimaki, L. Peltonen, M. Perola, and P. J. Karhunen
Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2008;
28(5):
983 - 989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A Zirngibl, J. S M Chan, and J. E Aubin
Estrogen receptor-related receptor {alpha} (ERR{alpha}) regulates osteopontin expression through a non-canonical ERR{alpha} response element in a cell context-dependent manner
J. Mol. Endocrinol.,
February 1, 2008;
40(2):
61 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Towler
Vascular Calcification: A Perspective On An Imminent Disease Epidemic
IBMS BoneKEy,
February 1, 2008;
5(2):
41 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Miller, W. C. Watson, K. A. Kerr, C. A. Labarrere, N. X. Chen, M. A. Deeg, and J. L. Unthank
Development of progressive aortic vasculopathy in a rat model of aging
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H2634 - H2643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Liu, L. Shi, and S. Wang
Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury
Am J Physiol Renal Physiol,
November 1, 2007;
293(5):
F1727 - F1735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jalvy, M.-A. Renault, L. L. S. Leen, I. Belloc, J. Bonnet, A.-P. Gadeau, and C. Desgranges
Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration
Cardiovasc Res,
September 1, 2007;
75(4):
738 - 747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2007;
16(6):
1087 - 1097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakamachi, T. Nomiyama, F. Gizard, E. B. Heywood, K. L. Jones, Y. Zhao, L. Fuentes, K. Takebayashi, Y. Aso, B. Staels, et al.
PPAR{alpha} Agonists Suppress Osteopontin Expression in Macrophages and Decrease Plasma Levels in Patients With Type 2 Diabetes
Diabetes,
June 1, 2007;
56(6):
1662 - 1670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jalvy, M.-A. Renault, L. Lam Shang Leen, I. Belloc, A. Reynaud, A.-P. Gadeau, and C. Desgranges
CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites
Circ. Res.,
May 11, 2007;
100(9):
1292 - 1299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, J. S. Bailey, D. Coss, B. Lin, R. Tsutsumi, M. A. Lawson, P. L. Mellon, and N. J. G. Webster
Activin Modulates the Transcriptional Response of LssT2 Cells to Gonadotropin-Releasing Hormone and Alters Cellular Proliferation
Mol. Endocrinol.,
November 1, 2006;
20(11):
2909 - 2930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-F. Lai, V. Seshadri, K. Huang, J.-S. Shao, J. Cai, R. Vattikuti, A. Schumacher, A. P. Loewy, D. T. Denhardt, S. R. Rittling, et al.
An Osteopontin-NADPH Oxidase Signaling Cascade Promotes Pro-Matrix Metalloproteinase 9 Activation in Aortic Mesenchymal Cells
Circ. Res.,
June 23, 2006;
98(12):
1479 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Vietor, R. Kurzbauer, G. Brosch, and L. A. Huber
TIS7 Regulation of the {beta}-Catenin/Tcf-4 Target Gene Osteopontin (OPN) Is Histone Deacetylase-dependent
J. Biol. Chem.,
December 2, 2005;
280(48):
39795 - 39801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhu, M. Casado, S. Vaulont, and K. Sharma
Role of Upstream Stimulatory Factors in Regulation of Renal Transforming Growth Factor-{beta}1
Diabetes,
July 1, 2005;
54(7):
1976 - 1984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sakamoto, M. Chen, T. Nakamura, T. Xie, G. Karsenty, and L. S. Weinstein
Deficiency of the G-protein {alpha}-Subunit Gs{alpha} in Osteoblasts Leads to Differential Effects on Trabecular and Cortical Bone
J. Biol. Chem.,
June 3, 2005;
280(22):
21369 - 21375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sellak, C. Choi, N. Browner, and T. M. Lincoln
Upstream Stimulatory Factors (USF-1/USF-2) Regulate Human cGMP-dependent Protein Kinase I Gene Expression in Vascular Smooth Muscle Cells
J. Biol. Chem.,
May 6, 2005;
280(18):
18425 - 18433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ogawa, J. F. Stone, Y. Takata, F. Blaschke, V. H. Chu, D. A. Towler, R. E. Law, W. A. Hsueh, and D. Bruemmer
Liver X Receptor Agonists Inhibit Cytokine-Induced Osteopontin Expression in Macrophages Through Interference With Activator Protein-1 Signaling Pathways
Circ. Res.,
April 15, 2005;
96(7):
e59 - e67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Renault, S. Jalvy, M. Potier, I. Belloc, E. Genot, L. V. Dekker, C. Desgranges, and A.-P. Gadeau
UTP Induces Osteopontin Expression through a Coordinate Action of NF{kappa}B, Activator Protein-1, and Upstream Stimulatory Factor in Arterial Smooth Muscle Cells
J. Biol. Chem.,
January 28, 2005;
280(4):
2708 - 2713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wang, J. Skorczewski, X. Feng, L. Mei, and J. E. Murphy-Ullrich
Glucose Up-regulates Thrombospondin 1 Gene Transcription and Transforming Growth Factor-{beta} Activity through Antagonism of cGMP-dependent Protein Kinase Repression via Upstream Stimulatory Factor 2
J. Biol. Chem.,
August 13, 2004;
279(33):
34311 - 34322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Abedin, Y. Tintut, and L. L. Demer
Vascular Calcification: Mechanisms and Clinical Ramifications
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2004;
24(7):
1161 - 1170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. El-Tanani, A. Platt-Higgins, P. S. Rudland, and F. C. Campbell
Ets Gene PEA3 Cooperates with {beta}-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription
J. Biol. Chem.,
May 14, 2004;
279(20):
20794 - 20806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vattikuti and D. A. Towler
Osteogenic regulation of vascular calcification: an early perspective
Am J Physiol Endocrinol Metab,
May 1, 2004;
286(5):
E686 - E696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weigert, K. Brodbeck, M. Sawadogo, H. U. Haring, and E. D. Schleicher
Upstream Stimulatory Factor (USF) Proteins Induce Human TGF-{beta}1 Gene Activation via the Glucose-response Element-1013/-1002 in Mesangial Cells: UP-REGULATION OF USF ACTIVITY BY THE HEXOSAMINE BIOSYNTHETIC PATHWAY
J. Biol. Chem.,
April 16, 2004;
279(16):
15908 - 15915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Shao, S.-L. Cheng, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler
Teriparatide (Human Parathyroid Hormone (1-34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice
J. Biol. Chem.,
December 12, 2003;
278(50):
50195 - 50202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-L. Cheng, J.-S. Shao, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler
Msx2 Promotes Osteogenesis and Suppresses Adipogenic Differentiation of Multipotent Mesenchymal Progenitors
J. Biol. Chem.,
November 14, 2003;
278(46):
45969 - 45977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Beck Jr. and N. Knecht
Osteopontin Regulation by Inorganic Phosphate Is ERK1/2-, Protein Kinase C-, and Proteasome-dependent
J. Biol. Chem.,
October 24, 2003;
278(43):
41921 - 41929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Renault, S. Jalvy, I. Belloc, S. Pasquet, S. Sena, M. Olive, C. Desgranges, and A.-P. Gadeau
AP-1 Is Involved in UTP-Induced Osteopontin Expression in Arterial Smooth Muscle Cells
Circ. Res.,
October 3, 2003;
93(7):
674 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Kumar and G. K. Owens
Combinatorial Control of Smooth Muscle-Specific Gene Expression
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2003;
23(5):
737 - 747.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|